NasdaqGS - Delayed Quote • USD
Omnicell, Inc. (OMCL)
At close: April 26 at 4:00 PM EDT
After hours: April 26 at 4:20 PM EDT
Earnings Estimate
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | 9 | 9 | 9 | 9 |
Avg. Estimate | -0.09 | 0.27 | 1.07 | 1.43 |
Low Estimate | -0.21 | 0.13 | 0.93 | 0.96 |
High Estimate | -0.04 | 0.37 | 1.16 | 2.14 |
Year Ago EPS | 0.39 | 0.57 | 1.91 | 1.07 |
Revenue Estimate
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | 8 | 8 | 9 | 9 |
Avg. Estimate | 236.75M | 261.88M | 1.06B | 1.12B |
Low Estimate | 234.91M | 248.55M | 1.05B | 1.05B |
High Estimate | 238.06M | 276.23M | 1.08B | 1.24B |
Year Ago Sales | 277.67M | 284.57M | 1.15B | 1.06B |
Sales Growth (year/est) | -14.70% | -8.00% | -7.30% | 5.40% |
Earnings History
CURRENCY IN USD | 3/31/2023 | 6/30/2023 | 9/30/2023 | 12/31/2023 |
---|---|---|---|---|
EPS Est. | 0.07 | 0.28 | 0.47 | 0.15 |
EPS Actual | 0.39 | 0.57 | 0.62 | 0.33 |
Difference | 0.32 | 0.29 | 0.15 | 0.18 |
Surprise % | 457.10% | 103.60% | 31.90% | 120.00% |
EPS Trend
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Current Estimate | -0.09 | 0.27 | 1.07 | 1.43 |
7 Days Ago | -0.09 | 0.27 | 1.07 | 1.43 |
30 Days Ago | -0.09 | 0.27 | 1.07 | 1.43 |
60 Days Ago | -0.09 | 0.27 | 1.07 | 1.43 |
90 Days Ago | 0.31 | 0.42 | 1.66 | 1.65 |
EPS Revisions
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | -- | -- |
Up Last 30 Days | -- | -- | -- | 1 |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
CURRENCY IN USD | OMCL | Industry | Sector | S&P 500 |
---|---|---|---|---|
Current Qtr. | -123.10% | -- | -- | 6.50% |
Next Qtr. | -52.60% | -- | -- | 12.00% |
Current Year | -44.00% | -- | -- | 5.30% |
Next Year | 33.60% | -- | -- | 13.10% |
Next 5 Years (per annum) | 12.00% | -- | -- | 11.09% |
Past 5 Years (per annum) | -4.95% | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
Maintains | Benchmark: Buy to Buy | 2/9/2024 |
Maintains | Wells Fargo: Equal-Weight to Equal-Weight | 2/9/2024 |
Upgrade | Wells Fargo: Underweight to Equal-Weight | 11/3/2023 |
Downgrade | BTIG: Buy to Neutral | 11/3/2023 |
Upgrade | Piper Sandler: Neutral to Overweight | 11/3/2023 |
Downgrade | Keybanc: Overweight to Sector Weight | 10/11/2023 |
Related Tickers
PRVA Privia Health Group, Inc.
18.26
+1.50%
EVH Evolent Health, Inc.
27.65
-2.37%
HSTM HealthStream, Inc.
25.61
-1.20%
PINC Premier, Inc.
20.96
+0.72%
NRC National Research Corporation
33.81
+0.65%
TBRG TruBridge, Inc.
8.04
+2.42%
BTSG BrightSpring Health Services, Inc.
10.58
+1.63%
HQY HealthEquity, Inc.
80.26
+1.54%
PGNY Progyny, Inc.
32.04
-1.42%
OPRX OptimizeRx Corporation
10.12
+15.00%